Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Experts are expecting strong performance driven by the robust sales of Lilly's blockbuster medications, particularly its insulin portfolio. However, there are also concerns about potential headwinds from rising c… Read More